Autres langues BBS-Bioactive Bone Substitutes Oyj

Actions

BONEH

FI4000260583

Marché Fermé - Nasdaq Helsinki Autres places de cotation 17:29:49 06/05/2024			Varia. 5j.	Varia. 1 janv.
0,404 ^EUR	-13,30 %		-13,86 %	-17,38 %

06/03	Bbs-Bioactive Bone Substitutes Oyj annonce la cessation des fonctions de Jari Kortesluoma en tant que membre de l'équipe de direction	CI
06/03	Oy Jamerco Ltd. met fin à son contrat de service avec BBS-Bioactive Bone Substitutes Oyj	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BBS-Bioactive Bone Substitutes – Insider information: The company updates the status of the CE marking process	05/05
BBS-Bioactive Bone Substitutes Plc: Annastiina Kauppinen appointed as Financial Manager of BBS-Bioactive Bone Substitutes Plc	25/04
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd	24/04
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024	17/04
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd	15/04
BBS-Bioactive Bone Substitutes Plc: The website's functionality restored	05/04
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024	03/04
BBS-Bioactive Bone Substitutes Plc: The website is under attack	26/03
Correction: BBS-Bioactive Bone Substitutes Plc: Annual Report for 2023 has been published	13/03
BBS-Bioactive Bone Substitutes Plc: Annual Report for 2023 has been published	08/03
Changes in BBS-Bioactive Bone Substitutes Plc’s Management Team	06/03
Changes in BBS-Bioactive Bone Substitutes Plc’s Management Team	06/03
Bbs-Bioactive Bone Substitutes Oyj Announces the Cessation of Jari Kortesluoma as Member of the Management Team	06/03
Bbs-Bioactive Bone Substitutes Oyj Announces the Cessation of Jari Kortesluoma as CFO	06/03
Oy Jamerco Ltd. Terminates Its Service Contract with BBS-Bioactive Bone Substitutes Oyj	06/03
BBS-Bioactive Bone Substitutes Plc: Financial Statements Bulletin 2023: Preparations for commercial phase initiated (unaudited)	26/02
BBS-Bioactive Bone Substitutes Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
BBS-Bioactive Bone Substitutes Obtains Financing for Working Capital	21/02
Inside information - BBS-Bioactive Bone Substitutes Plc: Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position	21/02
Inside information - BBS-Bioactive Bone Substitutes Plc: Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position	21/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BBS-Bioactive Bone Substitutes Oyj

Actions

BONEH

FI4000260583

Autres langues

Filtres